TABLE 1

Individual and encounter-level characteristics at baseline and censoring time

BaselineCensored#
Gender
 Male9137 (52.5)
 Female8266 (47.5)
Mutation category
 Class 14062 (23.3)
 Class 215043 (86.4)
 Class 31007 (5.8)
 Class 41068 (6.1)
 Class 51120 (6.4)
 Unknown668 (3.8)
 F508del only7827 (45.0)
Least severe mutation
 Class 1/213614 (78.2)
 Class 3950 (5.5)
 Class 4/52171 (12.5)
 Unknown668 (3.8)
Age
 12 to <18 years6554 (37.7)3694 (21.2)
 ≥18 years10849 (62.3)13709 (78.8)
FEV1pp
 Normal3923 (22.5)4313 (24.8)
 Mild4840 (27.8)5125 (29.4)
 Moderate4959 (28.5)5597 (32.2)
 Severe1210 (6.9)2256 (13.0)
 Unknown2471 (14.2)112 (0.6)
BMI
 Underweight1135 (6.5)1282 (7.4)
 Normal11517 (66.2)10940 (62.9)
 Overweight2345 (13.5)2852 (16.4)
 Obese839 (4.8)1045 (6.0)
 Unknown1567 (9.0)1284 (7.4)
Chronic macrolides7620 (43.8)8192 (47.1)
NTM positive4077 (23.4)
 Culture positive for MAB only1203 (6.9)
 Culture positive for MAC only2066 (11.9)
 Culture positive for other species only741 (4.3)
 Culture positive for multiple species67 (0.4)
Any modulator therapy7384 (42.4)
 Ever received ivacaftor monotherapy1893 (10.9)
 Ever received combination therapy5869 (33.7)
 Neither10019 (57.6)

Data are presented as n (%). FEV1pp: percentage predicted forced expiratory volume in 1 s; BMI: body mass index; NTM: nontuberculous mycobacteria; MAB: Mycobacterium abscessus; MAC: Mycobacterium avium complex. #: censor: NTM-positive culture or patient's last time point in dataset; : ≥1.